Momenta Phama (MNTA) Announces Dr. Jane F. Barlow to Board
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
Go back to Momenta Phama (MNTA) Announces Dr. Jane F. Barlow to Board
December 12, 2019 8:03 AM EST
Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA) today announced the pricing of its underwritten public offering of 14,516,130 shares of its common stock at the public offering price of $15.50 per share for total gross proceeds to Momenta of approximately $225.0 million. Momenta has granted the underwriters an option... More
December 11, 2019 9:19 AM EST
Today's Pre-Open Movers
Iterum Therapeutics plc (Nasdaq: ITRM) 46.2% LOWER; announced topline results from its Sulopenem for Resistant Enterobacteriaceae (SURE) 3 clinical trial in complicated intra-abdominal infections (cIAI). The primary U.S. Food and Drug Administration (FDA) endpoint was clinical response on Day 28 in the micro-MITT population. In this population, the difference in outcomes was 4.7% with a 95% confidence interval on that difference of -10.3% to 1.0%. Non-inferiority required that the lower limit of the difference in the outcome rates be >-10% for FDA.
GameStop (NYSE: GME)... More
